Advertisement

Influence of virgin coconut oil on blood coagulation factors, lipid levels and LDL oxidation in cholesterol fed Sprague–Dawley rats

Published:November 30, 2007DOI:https://doi.org/10.1016/j.eclnm.2007.09.003

      Summary

      Background aims

      Experimental and epidemiological studies indicate an association between dietary saturated fatty acids and thrombosis, but the effects of individual fatty acids on haemostasis are still controversial. The purpose of this research is to evaluate the effect of feeding virgin coconut oil (VCO) on blood coagulation factors, lipid levels and in vitro oxidation of LDL in comparison with copra oil (CO) and sunflower oil (SFO) in cholesterol (1%) and oil (10% w/w) fed rats.

      Methods

      Rats were given the test oils along with cholesterol for 45 days. After the experimental period, serum cholesterol and triglyceride levels, thrombotic risk factor levels viz. fibrin, fibrinogen, factor V, 6-ketoPGF1α and prothrombin time were measured. In vitro Cu2+ induced oxidation of LDL, erythrocyte membrane and LDL TBARS content and plasma antioxidant vitamins (A and E) were also evaluated.

      Results

      Administration of VCO showed significant antithrombotic effect compared to copra oil and the effects were comparable with sunflower oil fed animals. The antioxidant vitamin levels were found to be higher in VCO fed animals than other groups. LDL isolated from VCO fed animals when subjected to oxidant (Cu2+) in vitro showed significant resistance to oxidation as compared to the LDL isolated from other two groups. Dietary administration of VCO reduced the cholesterol and triglyceride levels and maintained the levels of blood coagulation factors. Results also indicate that VCO feeding can prevent the oxidation of LDL from oxidants. These properties of VCO may be attributed to the presence of biologically active unsaponifiable components viz. vitamin E, provitamin A, polyphenols and phytosterols.

      Keywords

      Introduction

      The formation of thrombus in the coronary or cerebral arteries is one of the major causes of morbidity and mortality throughout the world. The role of coagulation system in the process of coronary heart disease is increasingly recognized.
      • Kelleher C.C.
      Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
      Identified risk factors for thrombosis include genetics, diet, life style, smoking, lipids and cholesterol levels, molecular and circulating signals of chronic vascular inflammation.
      • Vinson J.A.
      • Mandarano M.A.
      • Shuta D.L.
      • Bagchi M.
      • Bagchi D.
      Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model.
      Animal models of thrombosis are critical to mimic the human diseases and have been widely implemented in antithrombotic drug development.
      • Leadley R.J.
      • Chi L.
      • Rebello S.S.
      • Gagnon A.
      Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents.
      • Wang X.
      • Xu L.
      An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research.
      Numerous studies have examined the relationship between dietary fat and cardiovascular disease (CVD), but the effects of individual fatty acids on haemostasis are still controversial.
      • Hoak J.C.
      Fatty acids in animals: thrombosis and hemostasis.
      • Knapp H.R.
      Dietary fatty acids in human thrombosis and hemostasis.
      Experimental and epidemiological studies indicate an association between dietary saturated fatty acids and venous thrombosis, but the chain of evidences lack documentation from prospective clinical studies.
      • Nordoy A.
      • Goodnight S.H.
      Dietary lipids and thrombosis. Relationships to atherosclerosis.
      However, it is now thought that some saturated fatty acids may not deserve this reputation.
      • Ferroni P.
      • Basili S.
      • Davi G.
      New insights in the pathogenesis of prothrombotic state associated with hypercholesterolemia.
      Previous reports suggest that saturated fatty acids and cholesterol each independently elevate blood cholesterol and low-density lipoprotein (LDL) concentrations.
      • Expert Panel
      Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II).
      Hypercholesterolemia and atherosclerotic disorders have been associated with a low-grade inflammation that involves not only the intrinsic cells of the artery wall, but also circulating cells, viz platelet, WBC, Hb and LDL.
      • Glass C.K.
      • Witztum J.L.
      Atherosclerosis. The road ahead.
      Free radical mediated oxidation of circulating LDL also plays a critical role in the progression of atherosclerosis.
      • Niki E.
      • Noguchi N.
      Effects of antioxidants against atherosclerosis.
      • Li L.X.
      • Chen J.X.
      • Liao D.F.
      • Yu L.
      Probucol inhibits oxidized-low density lipoprotein-induced adhesion of monocytes to endothelial cells by reducing P-selectin synthesis in vitro.
      Oxidized LDL stimulates platelet adhesion and aggregation by decreasing endothelial production of nitric oxide (NO) and increasing prostacyclin (PGI2) production.
      • Thorin E.
      • Hamilton C.A.
      • Dominiczak M.H.
      • Reid J.L.
      Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release.
      It also stimulates coagulation, reduces fibrinolytic activity of endothelium and may also contribute to its dysfunction and plaque disruption.
      • Xu X.P.
      • Meisel S.R.
      • Ong J.M.
      • Kaul S.
      • Cercek B.
      • Rajavashisth T.B.
      • et al.
      Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages.
      During the course of normal metabolism, reactive oxygen species (ROS) and free radicals are formed, which induce oxidative damage to biomolecules and play an important role in the pathological conditions such as atherosclerosis, aging and inflammatory diseases and variety of other disorders.
      • Sini H.
      • Devi K.S.
      Antioxidant activities of the chloroform extract of Solanum trilobatum.
      Oxidatively modified lipids cause both direct and indirect toxic effects on the vascular endothelium. The antioxidant system (AOS) that includes the enzymatic and non-enzymatic mechanisms for lipid peroxide (LPO) product inactivation confers protection from endothelial dysfunction.
      • Kowada M.
      • Ames A.
      • Majno G.
      • Wright R.L.
      Cerebral ischemia: an improved experimental method for study cardiovascular effects and demonstration of an early vascular lesion in rabbit.
      Virgin coconut oil (VCO), unlike the coconut oil obtained from dried copra, is extracted directly from coconut meat under mild temperature. This extraction process avoids the loss of minor components like provitamin A and vitamin E and polyphenols due to UV irradiation from sunlight during drying of copra. Sunflower oil is reported to have beneficial effect which is associated with coronary heart disease (CHD).
      • Ashton E.L.
      • Best J.D.
      • Ball M.J.
      Effects of monounsaturated enriched sunflower oil on CHD risk factors including LDL size and copper-induced LDL oxidation.
      We recently reported that VCO is more beneficial than copra oil (CO) and groundnut oil in lowering lipid levels and preventing the oxidation of LDL by physiological oxidants.
      • Nevin K.G.
      • Rajamohan T.
      Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation.
      In this context we proposed to examine the effect of virgin coconut oil on blood coagulation factors that contribute towards thrombosis, lipid levels and LDL oxidation compared to copra oil (CO) and sunflower oil (SFO) in cholesterol fed rats.

      Material and methods

       Chemicals

      α-Tocopherol, retinol, 6-ketoPGF1α, and prothrombin were purchased from Sigma Chemicals SA. All other chemicals used were of high analytical grade.

       Test oils

      Mature coconuts (West Coast Tall variety), grown at the Kerala University Campus were used for the extraction of copra oil and virgin coconut oil. (a) Virgin coconut oil: the solid endosperm of mature coconut was crushed, made into viscous slurry and squeezed through cheesecloth to obtain coconut milk which was refrigerated for 48 h to separate fat and water layer. Fat layer was carefully removed and subjected to mild heating (50 °C) in a thermostat oven. The obtained virgin oil was filtered through cheesecloth and was used for the present study.
      • Nevin K.G.
      • Rajamohan T.
      Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation.
      (b) Copra oil: coconut meat was dried in sunlight continuously for 4 days to remove moisture and the resulted copra was pressed in the mill to obtain copra oil. (c) Sunflower oil: sunflower oil (Gold Winner brand, Chennai) was purchased from the local market.

       Fatty acid analysis of VCO and CO

      The fatty acid composition of VCO and CO was analyzed by gas chromatography. Fats were methylated with trimethylsulfonium hydroxide.
      • Butte W.
      Rapid method for the determination of fatty acid profiles from fats and oils using trimethylsulphonium hydroxide for transesterification.
      Fatty acid methyl esters were separated by gas chromatography using a system (HP 5890, Hewlett Packard GmbH, Waldbronn, Germany) equipped with an automatic on-column injector, a polar capillary column (30 m FFAP, 0.53 mm I.D., Macherey and Nagel, Düren, Germany) and a flame ionisation detector.
      • Eder K.
      • Brandsch C.
      Effect of fatty acid composition of rapeseed oil on plasma lipids, fatty acid composition of tissues and susceptibility of low-density lipoprotein to lipid peroxidation in cholesterol-fed hamsters.
      Helium was used as carrier gas at a flow rate of 5.4 ml/min. Fatty acid methyl esters were identified by comparing their retention times with those of individually purified standards (Table 1).
      Table 1Fatty acid composition of the test oils
      Fatty acidsVCOCOSFO
      • Palozza P.
      • Sgarlata E.
      • Luberto C.
      • Piccioni E.
      • Anti M.
      • Marra G.
      • et al.
      n-3 Fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation.
      8:08.058.15<0.1
      10:05.425.560.0
      12:045.5143.550.0
      14:019.7418.380.1
      16:07.838.256.5
      18:03.142.654.2
      18:14.706.7018.7
      18:21.881.4968.6
      20:00.0860.0860.3
      20:10.0270.0420.3
      22:00.0160.0180.7
      24:00.0320.0650.2
      Values are mean of three estimations and are expressed as percentage amount.

       Animals

      All the animal cares and procedures were according to the guidelines of the Institutional Animal Ethical Committee (IAEC). One-month-old male Sprague–Dawley rats (100–130 g) bred in our department animal house was used for the study. The animals (6/group) were housed individually in polypropylene cages in a room maintained at 25±1 °C with a 12 h light and 12 h dark cycle.

       Experimental protocol

      A total of 18 rats were used to perform the present study. Rats were divided into three groups with six animals each as follows. (I) Copra oil (10% w/w)+1% cholesterol, (II) virgin coconut oil (10% w/w)+1% cholesterol, and (III) sunflower oil (10% w/w)+1% cholesterol. Oils were fed along with the normal laboratory diet (10 g/rat) (Amrut Laboratory Animal Feed, Mumbai) for 45 days. Gain in body weight was recorded weekly. After 45 days, animals were fasted overnight and sacrificed by sodium pentothal injection, blood and tissues were collected for various estimations.

       Estimation of hematological parameters

      Blood was drawn in WBC pipette followed by WBC diluting fluid (Turke's fluid). Mixture was mixed well and transferred into a counting chamber. WBC was counted uniformly in four large corner squares. For counting platelets, blood was drawn in an RBC pipette and diluted with 1% ammonium oxalate and charged the chamber and platelet counted using 40× objective lens in the 80 smaller squares of the chamber. Hemoglobin was estimated using cyanomethemoglobin. For RBC count blood was mixed with RBC diluting fluid and counted as described earlier.
      • Ramnik S.
      Clinical hematology, medical laboratory technology; methods and interpretations.

       Thrombotic risk factor levels

      Fibrinogen was estimated as described by Fearnley and Chakrabarti
      • Fearnley G.R.
      • Chakrabarti R.
      • Evans J.E.
      Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
      using a Fibroquant kit from Tulip Diagnostics (P) Ltd, Goa, India. Fibrin was estimated as described by King and Wootten.
      • King E.J.
      • Wootten I.D.P.
      Procedure for plasma.
      Plasma (0.05 ml) was diluted with 2 ml of isotonic saline and 0.2 ml of 2.5% calcium chloride solution was added. The mixture was kept at 37 °C for overnight until a clot was formed. The fibrin was carefully collected, pressed to remove liquid and washed with water. Sixty percent of perchloric acid (0.2 ml) was added and digested until it become colorless. Solution is cooled, mixed with 5 ml of water and 1 ml of Nesslers reagent. The color developed was read against reagent blank at 620 nm. Pure dry ammonium chloride (4 mg/100 ml water) was used as the standard.
      Prothrombin time was determined using liquiplastin kit from Tulip Diagnostics (P) Ltd, Goa, India. To 25 μl plasma at 37 °C forcibly added 0.2 ml of liquiplastin reagent (prewarmed at 37 °C for 3 min), simultaneously started a stopwatch and stopped as soon as the first fibrin strand was visible and the clot formation begins. Time is recorded in seconds and was taken as prothrombin time. Factor V was assayed by the method of Daniel.
      • Daniel L.K.
      Enzymes in blood clotting.
      The following cold reagents were taken in a small tube, 0.2 ml of prothrombin (200 U/ml), 0.2 ml of fibrinogen solution (0.5%) and 0.2 ml plasma diluted to 5% and allowed to stand at 37 °C for 4 min. Added 0.2 ml of CaCl2 solution (25 mM) and the coagulation time was recorded.

       Isolation and estimation of 6-ketoPGF1α by HPLC

      Lipids were extracted from the serum with chloroform:methanol (1:1). It was then filtered through a Whatman No 1 filter paper. The residue collected was evaporated to dryness under N2, after protein estimation. Residue was redissolved in 5 ml of ethanol and 15 ml of water was added, acidified to pH 3 with formic acid and kept for 24 h at 4 °C with constant shaking at 2 h interval. Sample was applied to a C18 Seppak catridge, and washed with 5 ml of water followed by 5 ml of 15% ethanol and 5 ml of hexane. The eicosanoids were eluted with 2.5 ml ethyl acetate.
      • Powell W.S.
      Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica.
      6-ketoPGF1α was detected using a C18 column (isocratically with acetonitrile:water:H3P04, 30:70:0.01, v/v, pH 2.95, flow rate 0.5 ml/min detection at 192 nm) in a Shimadzu S PDA 10 chromatograph.
      • Wong P.Y.
      • Malik K.U.
      • Taylor B.M.
      • Schneider W.P.
      • McGiff J.C.
      • Sun F.F.
      Epoxidation of prostacyclin in the rabbit kidney.

       Serum vitamins A and E

      Vitamins A and E content of serum were determined simultaneously by HPLC.
      • Catiganin G.L.
      An HPLC method for the simultaneous determination of retinol and α-tocopherol in plasma or serum.
      Briefly, 100 μl serum was added to 10 ml methanol containing 0.01% butylated hydroxytoluene (BHT) and hexane. Mixture was centrifuged and hexane layer collected, dissolved to dryness with N2 and added 2 ml 10% methanolic KOH. After keeping for 2 h at room temperature 4 ml hexane was added. Hexane layer was collected, evaporated under N2 and dissolved in 100 μl methanol and injected into HPLC column (C18 silica column, 100% methanol as mobile phase with 1.5 ml/min flow rate) and detected at 292 nm.

       Erythrocyte membrane isolation

      Blood from rats was drawn into tubes with potassium EDTA as anticoagulant. Plasma and platelets were removed by differential centrifugation (15 min, 1000×g). The erythrocytes were dispersed in isotonic phosphate buffer (0.119 mol PO4/L, pH 7.4) and washed two or three times by centrifugation (20 min, 1000×g).
      • Berlin E.
      • Bhathena S.J.
      • McClure D.
      • Peters R.C.
      Dietary menhaden and corn oils and the red blood cell membrane lipid composition and fluidity in hyper- and normocholesterolemic miniature swine.
      Erythrocyte membranes were prepared by hypotonic lysis in 7.6 mmol PO4/L (pH 7.4) according to the procedure of Dodge.
      • Dodge J.T.
      • Mitchell C.
      • Hanahan D.J.
      The preparation and chemical characteristics of hemoglobin free ghosts of human erythrocytes.
      Membrane preparations were washed in the 7.6 mmol PO4/L until the supernatant was clear to remove hemoglobin and other cytoplasmic components. From this aliquots were removed and TBARS content was measured.
      • Ohkawa H.
      • Ohishi N.
      • Yagi K.
      Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

       Isolation of LDL

      Blood from rats was collected into tubes containing potassium EDTA as anticoagulant. Plasma and platelets were removed by differential centrifugation (15 min, 1000×g). A volume of 3 ml plasma was centrifuged at d=1.006 kg/l in an ultracentrifuge (Sorvall Ultra 80) at 40,000 rpm using a T-865 rotor at 14 °C for 10 h.
      • Bairakatari E.
      • Elisaf M.
      • Tzallas C.
      Evaluation of five methods for determining low density lipoprotein cholesterol (LDL-C) in hemodialysis patients.
      After ultracentrifugation floating VLDL and chylomicrons were removed and LDL was separated by precipitation from the solution.
      • Alder L.
      • Hill J.S.
      • Frohlich J.
      Precipitation of apo B containing lipoproteins.
      Forty milliliters of 4% phosphotungstic acid in 1 M NaOH was added, stirred and 10 μl of 2 M MgCl2·6H2O was added and cenrtifuged at 1500×g for 30 min at 4 °C. The supernatant was discarded and the precipitated LDL was redissolved in 0.4 ml 0.5 M Na2CO3, kept in ice overnight and dialyzed against three changes of PBS for 12 h.
      • Nevin K.G.
      • Rajamohan T.
      Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation.

       Estimation of serum lipid levels

      Serum total cholesterol was estimated by the method as described by Abell et al.
      • Abell L.L.
      • Levy B.B.
      • Brodie B.B.
      • Kendall F.E.
      A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.
      Triglycerides were estimated by the method of Van Handel and Zilversmit.
      • Van Handel E.
      • Zilversmit D.B.
      Micromethod for the direct determination of serum triglycerides.

       Statistical analysis

      Analysis was done using SPSS 10. All values are mean±SEM calculated by one-way ANOVA. Duncan's variance was applied to assess significant differences of continuous variables among groups.

      Results

      There were no differences in weight gain pattern of rats between groups. Table 2 represents the levels of hematological parameters. In VCO fed animals the WBC, RBC and Hb levels were lower than CO but the result was similar to that obtained in SFO fed animals. Platelet count was reduced in Groups II and III animals fed VCO and SFO than Group I animals fed CO, which was found to be significantly increased.
      Table 2Hematological parameters of VCO, CO and SFO fed animals
      GroupsHb (g/100 ml)WBC (×103/c.mm)RBC (×106/c.mm)Platelet count (/c.mm)
      Copra oil14.03±0.127900±115.476.03±0.0926,500.00±288.67
      Virgin coconut oil13.37±0.18
      p<0.05 vs Group I.
      6600±57.73
      p<0.05 vs Group I.
      5.30±0.06
      p<0.05 vs Group I.
      24,000.00±57.74
      p<0.05 vs Group I.
      Sunflower oil12.23±0.17
      p<0.05 vs Group I.
      6800±57.74
      p<0.05 vs Group I.
      5.17±0.09
      p<0.05 vs Group I.
      24,066.67±88.19
      p<0.05 vs Group I.
      Values are mean±SEM of six rats.
      a p<0.05 vs Group I.
      Prothrombin time (PT) was significantly lowered in CO treated animals (10.16±0.16). VCO and SFO fed animals showed higher PT (11.25±0.14 and 11.37±0.08, respectively) (Table 3). Fibrin and fibrinogen levels were also found to be lower in VCO and SFO fed animals. In the case of CO fed animals, the levels of these parameters were significantly greater. The levels of factor V were found to be increased in CO fed groups (29.52±0.66) but there were no significant changes in VCO and SFO fed groups (30.28±0.11 and 30.01±0.24, respectively) (Table 3). 6-ketoPGF1α was slightly reduced in VCO fed animals. But their levels were similar in other two groups (Table 3).
      Table 3Blood coagulation factor levels of VCO, CO and SFO fed animals
      GroupsFibrin (mg/dl)Fibrinogen (mg/dl)Prothrombin time (s)Factor V (s)6-ketoPGF1α (pg/dl)
      Copra oil13.57±0.53296.67±7.2610.16±0.1629.52±0.6616.88±0.25
      Virgin coconut oil10.50±0.50232.93±4.3
      p<0.05 vs Group I.
      11.25±0.14
      p<0.05 vs Group I.
      30.28±0.11
      p<0.05 vs Group I.
      14.05±0.47
      p<0.05 vs Group I.
      Sunflower oil11.70±0.82225.13±4.9
      p<0.05 vs Group I.
      11.37±0.08
      p<0.05 vs Group I.
      30.01±0.24
      p<0.05 vs Group I.
      15.94±0.26
      Values are mean±SEM of six rats.
      a p<0.05 vs Group I.
      Vitamin A in the serum of VCO fed animals showed a significant change than SFO and CO fed animals. Vitamin E levels were greater in SFO group than VCO and CO fed animals with CO fed group showed a significantly lower level compared to VCO fed animals (Fig. 1).
      Figure thumbnail gr1
      Figure 1Levels of vitamins A and E levels of serum from test animals. Group I – copra oil (10%)+1% cholesterol, Group II – virgin coconut oil (10%)+1% cholesterol, and Group III – sunflower oil (10%)+1% cholesterol. Bars represent mean values±SEM of six rats. *p<0.05 vs Group I; and †p<0.05 vs Group III.
      Serum cholesterol levels in CO fed animal were significantly greater compared to CO and SFO fed animals. The values were similar in VCO and SFO fed animals. Serum triglyceride levels in CO fed animal were also significantly greater compared to CO and SFO fed animals. The values were similar in VCO and SFO fed animals (Fig. 2).
      Figure thumbnail gr2
      Figure 2Levels of serum total cholesterol and triglyceride levels of test animals. Group I – copra oil (10%)+1% cholesterol, Group II – virgin coconut oil (10%)+1% cholesterol, and Group III – sunflower oil (10%)+1% cholesterol. Bars represent mean values±SEM of six rats. *p<0.05 vs Group I.
      Erythrocyte membrane and LDL TBARS content of VCO fed animals were significantly lower than CO and SFO fed animals (Fig. 3). In SFO fed animas, LDL and erythrocyte membrane TBARS content were found to be significantly greater than other two oil fed groups.
      Figure thumbnail gr3
      Figure 3Levels of LDL and erythrocyte membrane TBARS content of test animals. Group I – copra oil (10%)+1% cholesterol, Group II – virgin coconut oil (10%)+1% cholesterol, and Group III – sunflower oil (10%)+1% cholesterol. Bars represent mean values±SEM of six rats. *p<0.05 vs Group I; and †p<0.05 vs Group III.
      LDL isolated from VCO fed animals when subjected to oxidation by Cu2+ was found to prevent oxidation than the LDL isolated from SFO and CO fed animals. In all the three cases the oxidation of LDL was found to increase with respect to time but the increase was slower in the case of LDL isolated from VCO fed animals compared to SFO and CO fed animals. The oxidation level was higher in LDL from SFO fed animals after 6 h indicated by high TBARS content. Oxidation level was lower in CO but not significant compared to VCO fed animals (Fig. 4).
      Figure thumbnail gr4
      Figure 4Cu2+ induced oxidation pattern of LDL isolated from test animals. Bars represent mean values±SEM of six rats. TBARS content is expressed as nM/mg protein. *p<0.05 vs Group I; and †p<0.05 vs Group III.

      Discussion

      The present study was conducted to evaluate the effect of virgin coconut oil (VCO) on blood coagulation factors, lipid levels and LDL oxidation as compared to copra oil (CO) and sunflower oil (SFO) in cholesterol co-administered rats. Supplementation of VCO diet showed significant beneficial effects on blood coagulation when compared to CO and SFO. The lipid levels, and thrombotic risk factors viz. platelets, fibrin, fibrinogen, and factor V were lower in rats fed VCO. Hematological factors viz. WBC, Hb and RBC were also lower in this group. Blood coagulation is the host mechanism involved in perfecting the integrity of the vascular system in which platelets are known to play an active role. Elevated platelet count also contribute to the circulation and progression of coronary artery narrowing by atherosclerotic plaques resulting in occlusive coronary arterial thrombosis and finally to unstable angina and myocardial infarction. WBC is suggested to promote myocardial ischemia by release of toxic oxygen metabolites. There are substantial evidence that dietary factors, particularly fatty acids may affect platelet function.
      The lower levels of fibrinogen and fibrin observed in VCO and SFO fed rats reflects the decreased blood-clotting tendency. The rate of conversion of fibrinogen to insoluble product fibrin is a key factor in haemostasis.
      • Brummel K.E.
      • Butenas S.
      • Mann K.G.
      An integrated study of fibrinogen during blood coagulation.
      Fibrinogen, an acute-phase protein, becomes elevated as a consequence of inflammatory reactions that occur during the development of atherosclerotic plaques.
      • Koopman J.
      • Maas A.
      • Rezaee F.
      • Havekes L.
      • Verheijen J.
      • Gijbels M.
      • et al.
      Fibrinogen and atherosclerosis: a study in transgenic mice.
      Previous studies have identified fibrinogen as a risk factor as powerful as cholesterol in producing ischemic events. Interaction of platelets with fibrinogen mediates a variety of responses including adhesion, platelet aggregation and fibrin clot retraction. We have also found decreased levels of factor V in VCO and SFO fed animals compared to CO fed group. Factor V, a large single chain plasma glycoproteins is an essential component of blood coagulation cascade and also an independent risk factor for myocardial infarction. During coagulation, factor V is converted to active co-factor, factor Va which combines with Xa and assemble to form prothrombinase complex, which converts prothrombin to thrombin.
      • Katzmann J.A.
      • Nesheim M.E.
      • Hibbard L.S.
      • Mann K.G.
      Isolation of functional human coagulation factor V by using a hybridoma antibody.
      Concentration of PGF1α was found to be lower in VCO fed animals. 6-ketoPGF1α is a stable metabolite of PGI2, which is a critical local regulation of a variety of cellular processes. 6-ketoPGF1α is found to possess cardioprotective effects in animal model of myocardial infarction. During platelet activation, arachidonate is released from the phospholipids and then converted into prostaglandin H2 and thromboxane A2, which strongly potentiate the activation process.
      • Needleman P.
      • Raz A.
      • Minkes M.S.
      • Ferrendelli J.A.
      • Sprecher H.
      Triene prostaglandins: prostacyclin and thromboxane biogenesis and unique biological properties.
      The low levels of 6-ketoPGF1α in VCO fed animals may be due to the lower level of linoleic acid which serves as the substrate for arachidonic acid synthesis.
      In the regulation of primary haemostasis, the interaction of blood vessels with platelet plays an essential role and its in vivo evaluation involves bleeding time measurement.
      • Cylwik D.
      • Mogielnicki A.
      • Kramkowski K.
      • Stokowski J.
      • Buczko W.
      Antithrombotic effect of L-arginine in hypertensive rats.
      Secondary haemostasis is another extremely important factor determining thrombus formation in vessels. Blood clotting can be inhibited by attenuation of plasma prothrombin activation system.
      • Stief T.W.
      • Weippert M.
      • Kretschmer V.
      • Renz H.
      Arginine inhibits hemostasis activation.
      Here we have observed an increase in prothrombin time (PT) in VCO and SFO compared to CO fed groups. Serum total cholesterol (TC) was found to be decreased in VCO fed animals and was comparable with SFO fed group. The TBARS content of isolated LDL and erythrocyte membrane of VCO fed animals were also significantly decreased compared to other two groups. The lower levels of LDL and VLDL cholesterol in VCO fed animals may be the reason for the above effect (unpublished report). Feeding cholesterol rich diet caused significant increase in the plasma, erythrocyte and liver TC, plasma TG and TBARS levels. Plasma and erythrocyte TBARS levels are markers of oxidative stress.
      Circulating lipid peroxides may promote lipid peroxidation of other circulating lipids and lipoproteins, resulting in disseminated endothelial dysfunction.
      • Sarandol E.
      • Safak O.
      • Dirican M.
      • Uncu G.
      Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia.
      MDA, a breakdown product of spontaneous fragmentation of peroxides form from polyunsaturated fatty acids (PUFA) mainly from the oxidation of cell membranes.
      • Buege J.A.
      • Aust S.D.
      Microsomal lipid peroxidation.
      The observed lower level of plasma and erythrocyte TBARS content may be due to the higher amount of antioxidant vitamins in the serum and lower amount of PUFA of VCO. SFO contain very high amount of unsaturated fatty acids (Table 3)
      • Hu X.
      • Jandacek R.J.
      • White W.S.
      Intestinal absorption of beta-carotene ingested with a meal rich in sunflower oil or beef tallow: postprandial appearance in triacylglycerol-rich lipoproteins in women.
      and is more susceptible to oxidation. Feeding of oils rich in polyunsaturated fatty acids (PUFA) results in their accumulation in cell membranes and increased the oxidative stress, since PUFAs are highly susceptible to peroxidation compared to monounsaturated and saturated fatty acids. This may be the reason for the higher TBARS formation in the plasma and erythrocyte membrane of SFO fed animals.
      • Hagve T.A.
      • Lie O.
      • Gronn M.
      The effect of dietary N-3 fatty acids on osmotic fragility and membrane fluidity of human erythrocytes.
      • Palozza P.
      • Sgarlata E.
      • Luberto C.
      • Piccioni E.
      • Anti M.
      • Marra G.
      • et al.
      n-3 Fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation.
      It is generally believed that the highly saturated nature of coconut fatty acids (Table 3) increases cholesterol synthesis in our body and thus contributes to higher incidence of heart disease. This contention, however, has been refuted scientifically.
      • Laureles L.R.
      • Rodriguez F.M.
      • Reano C.E.
      • Santos G.A.
      • Laurena A.C.
      • Mendoza E.M.
      Variability in fatty acid and triacylglycerol composition of the oil of coconut (Cocos nucifera L.) hybrids and their parentals.
      Available scientific reports showed that it is not hypercholesterolemic and atherogeneic.
      • Blackburn G.L.
      • Kater G.
      • Mascioli E.A.
      • Kowalchuck M.
      • Babayan V.K.
      • Bistrian B.R.
      A re-evaluation of coconut oils effect on serum cholesterol and atherogenesis.
      Medium chain triacyglycerols (MCTs) of coconut oil fed rats reduced storage fat accumulation, serum and tissue cholesterol and linoleate requirement.
      • Lim-Sylianco C.Y.
      • Mallorca R.
      • Serrano E.
      • Wu L.S.A.
      A comparison of germ cell antigenotoxic activity of non dietary coconut oil and soyabean oil.
      Compared to CO, VCO contain appreciable amounts of many biologically active minor components viz. polyphenols (80 mg/100 g oil) and antioxidant vitamins (30 μg/100 g oil), which may have an effect on blood coagulation. In vitro studies have proved that polyphenols inhibit platelet aggregation, increases the Ca2+ influx and mobilization of Ca2+ in endothelial cells.
      • Nestle P.
      Isoflavones: effects on cardiovascular risk and functions. International congress series.
      These compounds also reported to suppress adhesion molecules and inhibit experimental atherosclerosis. Diet supplemented with polyphenolic compounds improved the lipid metabolism and increased the plasma antioxidant potential especially in rats fed with added cholesterol.
      • Leontowicz H.
      • Gorinstein S.
      • Lojek A.
      • Leontowicz M.M.
      • Soliva-Fortuny R.
      • Park Y.-S.
      • et al.
      Comparative content of some bioactive compounds in apples, peaches and pears and their influence on lipids and antioxidant capacity in rats.
      Recently we have reported that VCO polyphenols can prevent the oxidation of LDL in in vitro conditions.
      • Nevin K.G.
      • Rajamohan T.
      Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation.
      They can trap reactive oxygen species from aqueous series such as plasma and interstitial fluid of arterial wall thereby inhibiting oxidation of LDL and showing atherosclerotic activity.
      • Yamakoshi J.
      • Kataoka S.
      • Koga T.
      • Ariga T.
      Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.
      We have observed an increase of serum vitamins A and E in VCO fed animals than CO fed animals and is comparable to SFO fed animals. The lower levels of these vitamins in CO fed animals may be due to the low content in CO (Table 3) that might have lost during the exposure of copra to UV radiation of sunlight during extraction process. Vitamin E has been implicated in the body's protective armory against diseases and is the major chain breaking lipophilic antioxidants in tissue and plasma.
      • Constantinescu A.
      • Han D.
      • Packer L.
      Vitamin E recycling in human erythrocyte membranes.
      Vitamin E decrease platelet aggregation by dephosphorylating protein kinase Cα (PKCα) and might thus affect thrombotic tendencies.
      • Steiner M.
      Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease.
      • Wu D.
      • Koga T.
      • Martin K.R.
      • Meydani M.
      Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes.
      Plasma vitamin E decreases the TBARS content in hypercholesterolemic rats by trapping the chain-propagating peroxyl radicals.
      • Gökkusu C.
      • Özden T.A.
      • Mostafa T.
      The relationship between oxidative stress and membrane ATPase enzyme activities in hypercholesterolemic rats supplemented with vitamin.
      It also suppresses the expression of adhesion molecules and chemokines by endothelial cells/monocytes in culture. Studies showed that antioxidant vitamins A and E were found to be decreased in the plasma of patients with angina and myocardial infarction.
      • Jayakumari N.
      • Ambikakumari V.
      • Balakrishnan K.G.
      • Iyer K.S.
      Antioxidant status in relation to free radical production during stable and unstable anginal syndromes.
      • Riemersma R.A.
      • Wood D.A.
      • Macintyre C.C.
      • Elton R.A.
      • Gey K.F.
      • Oliver M.F.
      Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene.
      LDL isolated from VCO treated animals showed a reduced TBARS content when treated with CuSO4. This may de due to the higher levels of antioxidants viz. vitamins E and A and polyphenols in the LDL which protect it from physiological oxidants. Oxidized LDL has been shown to be highly cytotoxic for vascular cells, to activate endothelial recruitment of leukocytes, macrophage cytokine production and stimulate smooth muscle cells (SMCs) proliferation.
      Oxysterols are responsible for most of the cytotoxic effects of oxidized LDL.
      • Nilsson J.
      Lipoproteins and inflammation in atherosclerosis.
      During the oxidation of LDL, the LDL molecule undergoes a large number of structural changes that alter its metabolism.
      • Kawai Y.
      • Saito A.
      • Shibata N.
      • Kobayashi M.
      • Yamada S.
      • Osawa T.
      • et al.
      Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis.
      Vascular thrombogenicity is induced by progressive LDL oxidation and that alterations of the antioxidant/oxidant balance of the LDL particle in favor of the antioxidant tone are protective against the thrombotic response triggered by oxidative stress.
      • Banfi C.
      • Camera M.
      • Giandomenico G.
      • Toschi V.
      • Arpaia M.
      • Mussoni L.
      • et al.
      Vascular thrombogenicity induced by progressive LDL oxidation: protection by antioxidants.
      It is generally accepted that the primary generation of lipid hydroperoxides in our body initiates a reaction cascade leading to rapid propagation and to amplification of the number of reactive oxygen species formed; this ultimately leads to extensive fragmentation of the fatty acid chains,
      • Esterbauer H.
      • Puhl H.
      • Dieber-Rotheneder M.
      • Waeg G.
      • Rabl H.
      Effect on oxidative modification of LDL.
      and conversion of the LDL to a more atherogenic form.
      • Quinn M.T.
      • Parthasarathy S.
      • Fong L.G.
      • Steinberg D.
      Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.
      Peroxidation of LDL with Cu2+ produced cholesteryl ester core aldehydes, such as 9-oxononanoylcholesterol (9-ONC) and 5-oxovaleroylcholesterol (5-OVC), as the major oxidized cholesteryl esters.
      • Ishii H.
      • Kizaki K.
      • Horie S.
      • Kazama M.
      Oxidized low density lipoprotein reduces thrombomodulin transcription in cultured human endothelial cells through degradation of the lipoprotein in lysosomes.
      Oxidized LDL reduces the fibrinolytic activity of endothelium by decreasing secretion of tissue-type plasminogen activator (tPA) and increasing release of plasminogen activator inhibitor-1 (PAI-1)
      • Grafe M.
      • Auch-Schwelk W.
      • Hertel H.
      • Terbeek D.
      • Steinheider G.
      • Loebe M.
      • et al.
      Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL.
      also stimulates coagulation by reducing thrombomodulin (TM) transcription.
      • Allison B.A.
      • Nilsson L.
      • Karpe F.
      • Hamsten A.
      • Eriksson P.
      Effects of native, triglyceride enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells.
      In conclusion, the results indicate that consumption of VCO supplemented diet exerts a significant antithrombotic effect, which is associated by suppression of platelet aggregation and low levels of cholesterol and triglycerides. VCO also prevented the formation of lipid peroxides in both erythrocyte membrane and LDL of experimental animals.

      Acknowledgements

      Authors are thankful to Prof. Klaus Eder, Dr. Corinna Brandsch and Wolfgang Bottcher (GC–MS-Labor), Institut fu¨r rnährungswissenschaften, Martin-Luther-universität Halle-Wittenberg, D-06108 Halle/Saale, Germany for the excellent assistance.

      References

        • Kelleher C.C.
        Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
        Eur J Epidemiol. 1992; 1: 79-82
        • Vinson J.A.
        • Mandarano M.A.
        • Shuta D.L.
        • Bagchi M.
        • Bagchi D.
        Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model.
        Mol Cell Biochem. 2002; 240: 99-103
        • Leadley R.J.
        • Chi L.
        • Rebello S.S.
        • Gagnon A.
        Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents.
        J Pharmacol Toxicol Methods. 2000; 43: 101-116
        • Wang X.
        • Xu L.
        An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research.
        Thromb Res. 2005; 115: 95-100
        • Hoak J.C.
        Fatty acids in animals: thrombosis and hemostasis.
        Am J Clin Nutr. 1997; 5: 1683S-1686S
        • Knapp H.R.
        Dietary fatty acids in human thrombosis and hemostasis.
        Am J Clin Nutr. 1997; 65: 1687S-1698S
        • Nordoy A.
        • Goodnight S.H.
        Dietary lipids and thrombosis. Relationships to atherosclerosis.
        Arterioscler Thromb Vasc Biol. 1990; 10: 149-163
        • Ferroni P.
        • Basili S.
        • Davi G.
        New insights in the pathogenesis of prothrombotic state associated with hypercholesterolemia.
        Recenti Prog Med. 2004; 95: 169-178
        • Expert Panel
        Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II).
        JAMA. 1993; 269: 3015-3023
        • Glass C.K.
        • Witztum J.L.
        Atherosclerosis. The road ahead.
        Cell. 2001; 104: 503-516
        • Niki E.
        • Noguchi N.
        Effects of antioxidants against atherosclerosis.
        Mol Cell Biochem. 2002; 234: 19-25
        • Li L.X.
        • Chen J.X.
        • Liao D.F.
        • Yu L.
        Probucol inhibits oxidized-low density lipoprotein-induced adhesion of monocytes to endothelial cells by reducing P-selectin synthesis in vitro.
        Endothelium. 1998; 6: 1-8
        • Thorin E.
        • Hamilton C.A.
        • Dominiczak M.H.
        • Reid J.L.
        Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release.
        Arterioscler Thromb. 1994; 14: 453-459
        • Xu X.P.
        • Meisel S.R.
        • Ong J.M.
        • Kaul S.
        • Cercek B.
        • Rajavashisth T.B.
        • et al.
        Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages.
        Circulation. 1999; 99: 993-998
        • Sini H.
        • Devi K.S.
        Antioxidant activities of the chloroform extract of Solanum trilobatum.
        Pharm Biol. 2004; 42: 462-466
        • Kowada M.
        • Ames A.
        • Majno G.
        • Wright R.L.
        Cerebral ischemia: an improved experimental method for study cardiovascular effects and demonstration of an early vascular lesion in rabbit.
        J Neurosurg. 1968; 28: 150-157
        • Ashton E.L.
        • Best J.D.
        • Ball M.J.
        Effects of monounsaturated enriched sunflower oil on CHD risk factors including LDL size and copper-induced LDL oxidation.
        J Am Coll Nutr. 2001; 20: 320-326
        • Nevin K.G.
        • Rajamohan T.
        Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation.
        Clin Biochem. 2004; 37: 830-835
        • Butte W.
        Rapid method for the determination of fatty acid profiles from fats and oils using trimethylsulphonium hydroxide for transesterification.
        J Chromatogr. 1983; 261: 142-145
        • Eder K.
        • Brandsch C.
        Effect of fatty acid composition of rapeseed oil on plasma lipids, fatty acid composition of tissues and susceptibility of low-density lipoprotein to lipid peroxidation in cholesterol-fed hamsters.
        Eur J Lipid Sci Technol. 2002; 104: 3-13
        • Ramnik S.
        Clinical hematology, medical laboratory technology; methods and interpretations.
        Med Pub (P) Ltd., India1999
        • Fearnley G.R.
        • Chakrabarti R.
        • Evans J.E.
        Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
        Lancet. 1966; 288: 757-761
        • King E.J.
        • Wootten I.D.P.
        Procedure for plasma.
        in: Microanalysis in medical biochemistry. 3rd ed. J&A Churchill (L), London1959
        • Daniel L.K.
        Enzymes in blood clotting.
        Methods Enzymol. 1955; 2: 139-166
        • Powell W.S.
        Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica.
        Prostaglandins. 1980; 20: 947-957
        • Wong P.Y.
        • Malik K.U.
        • Taylor B.M.
        • Schneider W.P.
        • McGiff J.C.
        • Sun F.F.
        Epoxidation of prostacyclin in the rabbit kidney.
        J Biol Chem. 1985; 260: 9150-9153
        • Catiganin G.L.
        An HPLC method for the simultaneous determination of retinol and α-tocopherol in plasma or serum.
        Methods Enzymol. 1986; 123: 215-219
        • Berlin E.
        • Bhathena S.J.
        • McClure D.
        • Peters R.C.
        Dietary menhaden and corn oils and the red blood cell membrane lipid composition and fluidity in hyper- and normocholesterolemic miniature swine.
        J Nutr. 1998; 128: 1421-1428
        • Dodge J.T.
        • Mitchell C.
        • Hanahan D.J.
        The preparation and chemical characteristics of hemoglobin free ghosts of human erythrocytes.
        Arch Biochem Biophys. 1963; 100: 119-130
        • Ohkawa H.
        • Ohishi N.
        • Yagi K.
        Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.
        Anal Biochem. 1979; 95: 351-358
        • Bairakatari E.
        • Elisaf M.
        • Tzallas C.
        Evaluation of five methods for determining low density lipoprotein cholesterol (LDL-C) in hemodialysis patients.
        Clin Biochem. 2001; 34: 593-602
        • Alder L.
        • Hill J.S.
        • Frohlich J.
        Precipitation of apo B containing lipoproteins.
        Clin Biochem. 2000; 33: 187-190
        • Abell L.L.
        • Levy B.B.
        • Brodie B.B.
        • Kendall F.E.
        A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.
        J Biol Chem. 1952; 195: 357-366
        • Van Handel E.
        • Zilversmit D.B.
        Micromethod for the direct determination of serum triglycerides.
        J Lab Clin Med. 1957; 50: 152-157
        • Brummel K.E.
        • Butenas S.
        • Mann K.G.
        An integrated study of fibrinogen during blood coagulation.
        J Biol Chem. 1999; 274: 22862-22870
        • Koopman J.
        • Maas A.
        • Rezaee F.
        • Havekes L.
        • Verheijen J.
        • Gijbels M.
        • et al.
        Fibrinogen and atherosclerosis: a study in transgenic mice.
        Fibrinolysis. 1997; 11: 19-21
        • Katzmann J.A.
        • Nesheim M.E.
        • Hibbard L.S.
        • Mann K.G.
        Isolation of functional human coagulation factor V by using a hybridoma antibody.
        Proc Natl Acad Sci U S A. 1981; 78: 162-166
        • Needleman P.
        • Raz A.
        • Minkes M.S.
        • Ferrendelli J.A.
        • Sprecher H.
        Triene prostaglandins: prostacyclin and thromboxane biogenesis and unique biological properties.
        Proc Natl Acad Sci U S A. 1979; 6: 944-948
        • Cylwik D.
        • Mogielnicki A.
        • Kramkowski K.
        • Stokowski J.
        • Buczko W.
        Antithrombotic effect of L-arginine in hypertensive rats.
        J Physiol Pharmacol. 2004; 55: 563-574
        • Stief T.W.
        • Weippert M.
        • Kretschmer V.
        • Renz H.
        Arginine inhibits hemostasis activation.
        Thromb Res. 2001; 104: 265-274
        • Sarandol E.
        • Safak O.
        • Dirican M.
        • Uncu G.
        Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia.
        Clin Biochem. 2004; 37: 990-996
        • Buege J.A.
        • Aust S.D.
        Microsomal lipid peroxidation.
        Methods Enzymol. 1978; 52: 302-310
        • Hu X.
        • Jandacek R.J.
        • White W.S.
        Intestinal absorption of beta-carotene ingested with a meal rich in sunflower oil or beef tallow: postprandial appearance in triacylglycerol-rich lipoproteins in women.
        Am J Clin Nutr. 2000; 71: 1170-1180
        • Hagve T.A.
        • Lie O.
        • Gronn M.
        The effect of dietary N-3 fatty acids on osmotic fragility and membrane fluidity of human erythrocytes.
        Scand J Clin Lab Invest. 1993; 215: 75-84
        • Palozza P.
        • Sgarlata E.
        • Luberto C.
        • Piccioni E.
        • Anti M.
        • Marra G.
        • et al.
        n-3 Fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation.
        Am J Clin Nutr. 1996; 64: 297-304
        • Laureles L.R.
        • Rodriguez F.M.
        • Reano C.E.
        • Santos G.A.
        • Laurena A.C.
        • Mendoza E.M.
        Variability in fatty acid and triacylglycerol composition of the oil of coconut (Cocos nucifera L.) hybrids and their parentals.
        J Agri Food Chem. 2002; 50: 1581-1586
        • Blackburn G.L.
        • Kater G.
        • Mascioli E.A.
        • Kowalchuck M.
        • Babayan V.K.
        • Bistrian B.R.
        A re-evaluation of coconut oils effect on serum cholesterol and atherogenesis.
        J Philipp Med Assoc. 1989; 65: 144-152
        • Lim-Sylianco C.Y.
        • Mallorca R.
        • Serrano E.
        • Wu L.S.A.
        A comparison of germ cell antigenotoxic activity of non dietary coconut oil and soyabean oil.
        Philipp J Coconut Stud. 1992; 17: 1-5
        • Nestle P.
        Isoflavones: effects on cardiovascular risk and functions. International congress series.
        Atherosclerosis XIII.Proceedings of the 13th International atherosclerosis symposium. 2004; 1262: 317-319
        • Leontowicz H.
        • Gorinstein S.
        • Lojek A.
        • Leontowicz M.M.
        • Soliva-Fortuny R.
        • Park Y.-S.
        • et al.
        Comparative content of some bioactive compounds in apples, peaches and pears and their influence on lipids and antioxidant capacity in rats.
        J Nutr Biochem. 2002; 13: 603-610
        • Yamakoshi J.
        • Kataoka S.
        • Koga T.
        • Ariga T.
        Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.
        Atherosclerosis. 1999; 142: 139-149
        • Constantinescu A.
        • Han D.
        • Packer L.
        Vitamin E recycling in human erythrocyte membranes.
        J Biol Chem. 1993; 268: 10906-10913
        • Steiner M.
        Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease.
        Nutr Rev. 1999; 57: 306-309
        • Wu D.
        • Koga T.
        • Martin K.R.
        • Meydani M.
        Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes.
        Atherosclerosis. 1999; 147: 297-307
        • Gökkusu C.
        • Özden T.A.
        • Mostafa T.
        The relationship between oxidative stress and membrane ATPase enzyme activities in hypercholesterolemic rats supplemented with vitamin.
        Eur J Med. 2004; 4: 70-76
        • Jayakumari N.
        • Ambikakumari V.
        • Balakrishnan K.G.
        • Iyer K.S.
        Antioxidant status in relation to free radical production during stable and unstable anginal syndromes.
        Atherosclerosis. 1992; 94: 183-190
        • Riemersma R.A.
        • Wood D.A.
        • Macintyre C.C.
        • Elton R.A.
        • Gey K.F.
        • Oliver M.F.
        Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene.
        Lancet. 1991; 337: 1-5
        • Nilsson J.
        Lipoproteins and inflammation in atherosclerosis.
        Fibrinolysis. 1997; 11: 129-132
        • Kawai Y.
        • Saito A.
        • Shibata N.
        • Kobayashi M.
        • Yamada S.
        • Osawa T.
        • et al.
        Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis.
        J Biol Chem. 2003; 278: 21040-21049
        • Banfi C.
        • Camera M.
        • Giandomenico G.
        • Toschi V.
        • Arpaia M.
        • Mussoni L.
        • et al.
        Vascular thrombogenicity induced by progressive LDL oxidation: protection by antioxidants.
        Thromb Haemost. 2003; 89: 544-553
        • Esterbauer H.
        • Puhl H.
        • Dieber-Rotheneder M.
        • Waeg G.
        • Rabl H.
        Effect on oxidative modification of LDL.
        Ann Med. 1991; 23: 573-581
        • Quinn M.T.
        • Parthasarathy S.
        • Fong L.G.
        • Steinberg D.
        Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.
        Proc Natl Acad Sci U S A. 1987; 84: 2995-2998
        • Ishii H.
        • Kizaki K.
        • Horie S.
        • Kazama M.
        Oxidized low density lipoprotein reduces thrombomodulin transcription in cultured human endothelial cells through degradation of the lipoprotein in lysosomes.
        J Biol Chem. 1996; 271: 8458-8465
        • Grafe M.
        • Auch-Schwelk W.
        • Hertel H.
        • Terbeek D.
        • Steinheider G.
        • Loebe M.
        • et al.
        Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL.
        Atherosclerosis. 1998; 137: 87-95
        • Allison B.A.
        • Nilsson L.
        • Karpe F.
        • Hamsten A.
        • Eriksson P.
        Effects of native, triglyceride enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells.
        Arterioscler Thromb Vasc Biol. 1999; 19: 1354-1360